Alan Melcher

16.6k citations
247 papers · 10.7k · 1 hit paper · h-index 61

Impact in

  • Genetics top 0.1%
    • Virus-based gene therapy research
  • Oncology top 0.2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Virus-based gene therapy research 144
    • CAR-T cell therapy research 69
    • Cancer Immunotherapy and Biomarkers 28

Alan Melcher

242 papers receiving 10.5k citations

Alan Melcher's Hit Papers

Inflammatory microenvironment remodelling by tumour cells after radiotherapy 2020 · 630 citations
6300+2+4Years since publication200400600

Peers

Alan Melcher
Comparison fields: 5 of 121
  • Genetics 5.4k
  • Oncology 4.9k
  • Immunology 3.3k
  • Biotechnology 1.3k
  • Infectious Diseases 1.5k
Replace Richard G. Vile with:
Richard G. Vile United States
Hardev Pandha United Kingdom
Akseli Hemminki Finland
David H. Kirn United States
Patrick W.K. Lee Canada
Özlem Türeci Germany
Jean Rommelaere Germany
Dmitriy Zamarin United States
J. Ignacio Casal Spain
Nancy C. Reich United States
Alan Melcher relative to Richard G. Vile United States Richard G. Vile's profile →
Citations per field
00.5×1.5×
Richard G. Vile · 1×
Citations per year

Countries citing papers authored by Alan Melcher

Since Specialization
Citations

This map shows the geographic impact of Alan Melcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Melcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Melcher more than expected).

Fields of papers citing papers by Alan Melcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Melcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Melcher. The network helps show where Alan Melcher may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Melcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Melcher Line = papers co-authored together Alan Melcher links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 247 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Hit paper breakdown →
2020630
2 1998383
3 1999265
4 2011195
5 2008186
6 2018166
7 2009165
8 2015157
9 2011156
10 2012154
11 2008152
12 2008152
13 2019150
14 2008150
15 2008146
16 2009142
17 2009137
18 2011128
19 2008126
20 2007117

About Alan Melcher

Alan Melcher is a scholar working on Genetics, Oncology, Immunology, Molecular Biology and Biotechnology, having authored 247 papers that have together received 10.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (144 papers), CAR-T cell therapy research (69 papers), Immunotherapy and Immune Responses (54 papers), Cancer Research and Treatments (47 papers), Viral gastroenteritis research and epidemiology (37 papers), Cancer Immunotherapy and Biomarkers (28 papers), RNA Interference and Gene Delivery (24 papers) and Immune Cell Function and Interaction (16 papers). The work is most often cited by research in Genetics (5.4k citations), Oncology (4.9k citations), Immunology (3.3k citations), Biotechnology (1.3k citations) and Infectious Diseases (1.5k citations). Alan Melcher has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Richard G. Vile, Kevin J. Harrington, Hardev Pandha, Fiona Errington‐Mais, Peter J. Selby, Timothy Kottke, Jill Thompson, Rosa María Díaz, Robin Prestwich and Elizabeth J. Ilett. Their work appears in journals such as Clinical Cancer Research, Molecular Therapy, Gene Therapy, Clinical Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact